Literature DB >> 25099897

From cancer screening to treatment: service delivery and referral in the National Breast and Cervical Cancer Early Detection Program.

Jacqueline W Miller1, Vivien Hanson, Gale D Johnson, Janet E Royalty, Lisa C Richardson.   

Abstract

The National Breast and Cervical Cancer Early Detection Program (NBCCEDP) provides breast and cervical cancer screening and diagnostic services to low-income and underserved women through a network of providers and health care organizations. Although the program serves women 40-64 years old for breast cancer screening and 21-64 years old for cervical cancer screening, the priority populations are women 50-64 years old for breast cancer and women who have never or rarely been screened for cervical cancer. From 1991 through 2011, the NBCCEDP provided screening and diagnostic services to more than 4.3 million women, diagnosing 54,276 breast cancers, 2554 cervical cancers, and 123,563 precancerous cervical lesions. A critical component of providing screening services is to ensure that all women with abnormal screening results receive appropriate and timely diagnostic evaluations. Case management is provided to assist women with overcoming barriers that would delay or prevent follow-up care. Women diagnosed with cancer receive treatment through the states' Breast and Cervical Cancer Treatment Programs (a special waiver for Medicaid) if they are eligible. The NBCCEDP has performance measures that serve as benchmarks to monitor the completeness and timeliness of care. More than 90% of the women receive complete diagnostic care and initiate treatment less than 30 days from the time of their diagnosis. Provision of effective screening and diagnostic services depends on effective program management, networks of providers throughout the community, and the use of evidence-based knowledge, procedures, and technologies.
© 2014 American Cancer Society.

Entities:  

Keywords:  breast cancer; case management; cervical cancer; early detection; screening

Mesh:

Year:  2014        PMID: 25099897      PMCID: PMC4459516          DOI: 10.1002/cncr.28823

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  41 in total

1.  The risk of cancer risk prediction: "What is my risk of getting breast cancer"?

Authors:  Joann G Elmore; Suzanne W Fletcher
Journal:  J Natl Cancer Inst       Date:  2006-12-06       Impact factor: 13.506

2.  Recent declines in hormone therapy utilization and breast cancer incidence: clinical and population-based evidence.

Authors:  Christina A Clarke; Sally L Glaser; Connie S Uratsu; Joseph V Selby; Larry H Kushi; Lisa J Herrinton
Journal:  J Clin Oncol       Date:  2006-11-20       Impact factor: 44.544

3.  Effect of screening and adjuvant therapy on mortality from breast cancer.

Authors:  Donald A Berry; Kathleen A Cronin; Sylvia K Plevritis; Dennis G Fryback; Lauren Clarke; Marvin Zelen; Jeanne S Mandelblatt; Andrei Y Yakovlev; J Dik F Habbema; Eric J Feuer
Journal:  N Engl J Med       Date:  2005-10-27       Impact factor: 91.245

4.  Missed opportunities for early diagnosis of cancer of the cervix.

Authors:  R G Fruchter; J Boyce; M Hunt
Journal:  Am J Public Health       Date:  1980-04       Impact factor: 9.308

5.  Global cancer statistics, 2002.

Authors:  D Max Parkin; Freddie Bray; J Ferlay; Paola Pisani
Journal:  CA Cancer J Clin       Date:  2005 Mar-Apr       Impact factor: 508.702

6.  The National Breast and Cervical Cancer Early Detection Program: a comprehensive public health response to two major health issues for women.

Authors:  R M Henson; S W Wyatt; N C Lee
Journal:  J Public Health Manag Pract       Date:  1996

7.  Modeling the impact of treatment and screening on U.S. breast cancer mortality: a Bayesian approach.

Authors:  Donald A Berry; Lurdes Inoue; Yu Shen; John Venier; Debbie Cohen; Melissa Bondy; Richard Theriault; Mark F Munsell
Journal:  J Natl Cancer Inst Monogr       Date:  2006

8.  Meeting the mammography screening needs of underserved women: the performance of the National Breast and Cervical Cancer Early Detection Program in 2002-2003 (United States).

Authors:  Florence K L Tangka; Joseph Dalaker; Sajal K Chattopadhyay; James G Gardner; Janet Royalty; Ingrid J E Hall; Amy DeGroff; Donald K Blackman; Ralph J Coates
Journal:  Cancer Causes Control       Date:  2006-11       Impact factor: 2.506

9.  Mass screening in low-income populations: the challenges of securing diagnostic and treatment services in a national cancer screening program.

Authors:  P M Lantz; L C Richardson; L E Sever; D J Macklem; M L Hare; C E Orians; R Henson
Journal:  J Health Polit Policy Law       Date:  2000-06       Impact factor: 2.265

10.  Quality assurance through quality improvement and professional development in the National Breast and Cervical Cancer Early Detection Program.

Authors:  Elvira J Siegl; Jacqueline W Miller; Kris Khan; Susan E Harris
Journal:  Cancer       Date:  2014-08-15       Impact factor: 6.860

View more
  23 in total

1.  Determinants of Abnormal Cervical Cancer Screening Follow-Up And Invasive Cervical Cancer Among Uninsured and Underinsured Women in New Jersey.

Authors:  Jennifer Tsui; Adana A Llanos; Michelle Doose; David Rotter; Antoinette Stroup
Journal:  J Health Care Poor Underserved       Date:  2019

2.  Breast and cervical cancers diagnosed and stage at diagnosis among women served through the National Breast and Cervical Cancer Early Detection Program.

Authors:  Jacqueline W Miller; Janet Royalty; Jane Henley; Arica White; Lisa C Richardson
Journal:  Cancer Causes Control       Date:  2015-02-28       Impact factor: 2.506

3.  Preventing premature deaths from breast and cervical cancer among underserved women in the United States: insights gained from a national cancer screening program.

Authors:  Mary C White; Faye L Wong
Journal:  Cancer Causes Control       Date:  2015-03-18       Impact factor: 2.506

4.  Reported breast symptoms in the National Breast and Cervical Cancer Early Detection Program.

Authors:  A Blythe Ryerson; Jacqueline Miller; Christie R Eheman
Journal:  Cancer Causes Control       Date:  2015-03-10       Impact factor: 2.506

5.  Comparing Breast Cancer Outcomes Between Medicaid and the Ohio Breast and Cervical Cancer Early Detection Program.

Authors:  Siran M Koroukian; Paul M Bakaki; Mark Schluchter; Cynthia Owusu; Gregory S Cooper; Susan A Flocke
Journal:  J Oncol Pract       Date:  2015-09-15       Impact factor: 3.840

6.  Forward. The reach and health impacts of the national breast and cervical cancer early detection program.

Authors:  Gery P Guy; Florence K L Tangka; Ingrid J Hall; Jacqueline W Miller; Janet Royalty
Journal:  Cancer Causes Control       Date:  2015-03-21       Impact factor: 2.506

7.  Cost-effectiveness of breast cancer screening in the National Breast and Cervical Cancer Early Detection Program.

Authors:  Sun Hee Rim; Benjamin T Allaire; Donatus U Ekwueme; Jacqueline W Miller; Sujha Subramanian; Ingrid J Hall; Thomas J Hoerger
Journal:  Cancer Causes Control       Date:  2019-05-16       Impact factor: 2.506

8.  The role and contribution of treatment and imaging modalities in global cervical cancer management: survival estimates from a simulation-based analysis.

Authors:  Zachary J Ward; Surbhi Grover; Andrew M Scott; Sungmin Woo; Dina H Salama; Elizabeth C Jones; Tarek El-Diasty; Bradley R Pieters; Edward L Trimble; H Alberto Vargas; Hedvig Hricak; Rifat Atun
Journal:  Lancet Oncol       Date:  2020-08       Impact factor: 41.316

9.  Cervical cancer screening among HIV-infected women in an urban, United States safety-net healthcare system.

Authors:  Arti Barnes; Andrea C Betts; Eric K Borton; Joanne M Sanders; Sandi L Pruitt; Claudia Werner; Andres Bran; Carolee D Estelle; Bijal A Balasubramanian; Stephen J Inrig; Ethan A Halm; Celette Sugg Skinner; Jasmin A Tiro
Journal:  AIDS       Date:  2018-08-24       Impact factor: 4.177

10.  Association between micronucleus frequency and cervical intraepithelial neoplasia grade in Thinprep cytological test and its significance.

Authors:  Yong-Hua Shi; Bo-Wei Wang; Talaf Tuokan; Qiao-Zhi Li; Ya-Jing Zhang
Journal:  Int J Clin Exp Pathol       Date:  2015-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.